Morgan Stanley raised the firm’s price target on Houlihan Lokey (HLI) to $192 from $159 and keeps an Overweight rating on the shares. The firm, which raised its Midcap Advisors Industry View to In-Line due to improving market conditions for dealmaking, expects the pipeline to start moving again, driven by rapidly improving market conditions, regulatory clarity, significant pent-up demand, and structural drivers of M&A, the analyst tells investors in a group note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
- Houlihan Lokey announces Rogowski joined as Managing Director
- Houlihan Lokey price target raised to $185 from $183 at Keefe Bruyette
- Houlihan Lokey’s Record Revenue Highlights Earnings Call
- Houlihan Lokey price target raised to $185 from $170 at Wells Fargo
- Houlihan Lokey: Strong Financial Performance and Strategic Growth Drive Buy Rating